Overview
Effect of Phenazopyridine on Prolapse Surgery Voiding Trials
Status:
Completed
Completed
Trial end date:
2019-02-28
2019-02-28
Target enrollment:
0
0
Participant gender:
Female
Female
Summary
To determine if phenazopyridine reduces the rate of postoperative urinary retention after pelvic organ prolapse surgery.Phase:
Phase 3Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
University of Massachusetts, Worcester
Criteria
Inclusion Criteria:- Women undergoing overnight admission after prolapse surgery
Exclusion Criteria:
- Unable to provide consent
- Under 18 years of age
- Pregnant women
- Prisoners
- Using intermittent self-catheterization preoperatively
- Neurological disease or spinal cord injury resulting in voiding dysfunction
- Undergoing spinal or epidural anesthesia for the procedure
- Allergy to phenazopyridine
- Renal insufficiency
- Liver disease
- Intra-operative bladder injury necessitating use of prolonged indwelling Foley
catheter